Please spare 3 minutes to help us improve your experience on the UK Research and Innovation website.Take our survey. | 2.4m to fund trial of ketamine-assisted therapy for alcoholism 16-12-2022 01:58 PM GMT A 2.4 million phase III trial delivered across 7 NHS sites will investigate whether ketamine-assisted therapy could help alcoholics stay off alcohol for longer. Led by the University of Exeter, the new trial is being funded by the Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR) through their Efficacy [] Powerful new instrument to advance study of molecules 16-12-2022 10:00 AM GMT A powerful new Nuclear Magnetic Resonance (NMR) instrument will be used to improve battery design and drug design, and lead antimicrobial resistance research. The new instrument will be the UKs most powerful NMR instrument at 1.2 GHz and 1 of only 7 such machines currently operating around the world. It will be procured by a [] | | |
|
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.
This service is provided to you at no charge by UK Research and Innovation.
This email was sent to [email protected] using GovDelivery Communications Cloud, on behalf of: UK Research and Innovation UK Research and Innovation, Polaris House, Swindon, SN2 1FL | |